To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ILF3TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
528 representative clones for gene ILF3 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DC320902 brain .a 1 to 496 1 to 496   tiling clone,   496/496
(100 %)
0 diff
(100 %id)
NM_017620.2   .a 4 to 6122 1 to 6119 exact RefSeq, AAA Possibly primed on the genome, locally A rich (15/18 A in genome downstream of last aligned base) 6119/6119
(100 %)
0 diff
(100 %id)
DC372408   .a 21 to 578 1 to 558       558/558
(100 %)
0 diff
(100 %id)
DC397931 testis .a 21 to 582 1 to 562       562/562
(100 %)
0 diff
(100 %id)
DC354841   .a 29 to 582 1 to 554       554/554
(100 %)
0 diff
(100 %id)
DC370380   .a 29 to 580 1 to 552       552/552
(100 %)
0 diff
(100 %id)
DC396556 testis .a 29 to 509 1 to 481       481/481
(100 %)
0 diff
(100 %id)
CR986443 T-Lymphocytes .a 31 to 943 1 to 915       915/915
(100 %)
2 diff
(99.8 %id)
BQ428603 leiomyosarcoma, uterus .a 41 to 877 1 to 838       838/903
(92 %)
16 diff
(98.3 %id)
U10324   .a 52 to 3552 1 to 3502 D50H L89C V95A L97P V98G ...     3502/3505
(99 %)
38 diff
(99.0 %id)
CN422255 embryonic stem cells, cell lines H1, H7, andH9 .a 53 to 782 1 to 730       730/730
(100 %)
0 diff
(100 %id)
DB214074 trachea .a 55 to 613 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
AL537835 brain, fetal brain .a 63 to 1164 1 to 1093       1093/1093
(100 %)
16 diff
(98.6 %id)
DA099300 cerebellum .a 90 to 639 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA316233 hippocampus .a 90 to 567 2 to 479   capped   478/478
(100 %)
0 diff
(100 %id)
DA398730 thalamus .a 90 to 600 2 to 512   capped   511/511
(100 %)
0 diff
(100 %id)
DA800601 brain .a 90 to 640 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DB070832 testis .a 90 to 561 2 to 473   capped   472/472
(100 %)
0 diff
(100 %id)
CN422199 embryonic stem cells, cell lines H1, H7, andH9 .a 92 to 767 1 to 676       676/676
(100 %)
0 diff
(100 %id)
DA759523   .a 92 to 590 2 to 500   capped   499/499
(100 %)
0 diff
(100 %id)
BU179050 leiomyosarcoma, uterus .a 94 to 972 1 to 884       884/907
(97 %)
13 diff
(98.6 %id)
DA666372   .a 95 to 639 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA249179 brain .a 97 to 692 2 to 597   capped   596/596
(100 %)
0 diff
(100 %id)
DB229433 trachea .a 97 to 646 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA577312   .a 99 to 645 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
DA862003 placenta .a 100 to 625 2 to 527   capped   526/526
(100 %)
0 diff
(100 %id)
DA788676 brain .a 103 to 634 2 to 533   capped   532/532
(100 %)
0 diff
(100 %id)
DA967228 stomach .a 105 to 664 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
CX165371 human embryonic stem cells differentiated toan early endodermal cell type .a 109 to 945 1 to 837       837/837
(100 %)
0 diff
(100 %id)
DA112312 cerebellum .a 114 to 685 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA222145 brain .a 114 to 668 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA223090 brain .a 114 to 589 2 to 477   capped   476/476
(100 %)
0 diff
(100 %id)
DA393340 thalamus .a 114 to 710 2 to 598   capped   597/597
(100 %)
0 diff
(100 %id)
BX425589 neuroblastoma .a 114 to 955 1 to 842       842/842
(100 %)
0 diff
(100 %id)
DA441180 tongue, tumor tissue .a 114 to 699 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
DA442590 tongue, tumor tissue .a 114 to 686 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA481185   .a 114 to 658 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
AU123620   .a 114 to 815 2 to 702   capped   701/701
(100 %)
3 diff
(99.6 %id)
DA800340 brain .a 114 to 625 2 to 513   capped   512/512
(100 %)
0 diff
(100 %id)
DA865128 placenta .a 114 to 677 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA999983 breast, tumor tissue .a 114 to 661 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DB009426 colon, tumor tissue .a 114 to 683 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DB097338 testis .a 114 to 694 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
DB100685 testis .a 114 to 667 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DB283374 uterus .a 114 to 658 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA622704 Kidney .a 117 to 668 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
X98264 blood .a 117 to 1639 1 to 1523   tiling clone,   1523/1523
(100 %)
0 diff
(100 %id)
CN422168 embryonic stem cells, cell lines H1, H7, andH9 .a 118 to 694 1 to 577       577/577
(100 %)
0 diff
(100 %id)
DA101631 cerebellum .a 119 to 661 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DA122019 cerebellum .a 119 to 644 2 to 527   capped   526/526
(100 %)
0 diff
(100 %id)
DA127909 cerebellum .a 119 to 691 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA458126 tongue, tumor tissue .a 119 to 691 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA851463 placenta .a 120 to 710 2 to 592   capped   591/591
(100 %)
0 diff
(100 %id)
DB231238 trachea .a 120 to 691 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
BU189012 melanotic melanoma, skin .a 131 to 874 1 to 749       749/845
(88 %)
9 diff
(99.0 %id)
CN422211 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 132 to 846 1 to 715       715/715
(100 %)
0 diff
(100 %id)
CN422182 embryonic stem cells, cell lines H1, H7, andH9 .a 135 to 836 1 to 702       702/702
(100 %)
1 diff
(99.9 %id)
CN422204 embryonic stem cells, cell lines H1, H7, andH9 .a 135 to 727 1 to 593       593/593
(100 %)
0 diff
(100 %id)
CB216905 normal endometrium, mid-secretory phase,cycle day 23, uterus .a 145 to 668 1 to 524       524/524
(100 %)
0 diff
(100 %id)
CN422207 embryonic stem cells, cell lines H1, H7, andH9 .a 188 to 868 1 to 680       680/680
(100 %)
1 diff
(99.9 %id)
CN422238 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 188 to 703 1 to 516       516/516
(100 %)
0 diff
(100 %id)
CN422242 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 188 to 668 1 to 481       481/481
(100 %)
0 diff
(100 %id)
AL562848 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 225 to 1144 1 to 909       909/909
(100 %)
27 diff
(97.1 %id)
CN422185 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 244 to 782 1 to 539       539/539
(100 %)
0 diff
(100 %id)
AL043789 testis .a 264 to 900 1 to 637       637/637
(100 %)
0 diff
(100 %id)
CB216582 normal endometrium, mid-secretory phase,cycle day 23, uterus .a 302 to 940 1 to 639       639/639
(100 %)
0 diff
(100 %id)
EL737023 mixed .a 321 to 995 1 to 669       672/672
(100 %)
11 diff
(98.4 %id)
CR998129 T-Lymphocytes .a 336 to 1035 1 to 701       701/708
(99 %)
2 diff
(99.8 %id)
CB119297 Liver .a 387 to 869 1 to 483       483/483
(100 %)
0 diff
(100 %id)
BQ890269 brain, neuroblastoma, cell line .a 390 to 1269 1 to 880       880/881
(99 %)
6 diff
(99.4 %id)
CN422240 embryonic stem cells, DMSO-treated H9 cellline .a 424 to 972 1 to 549       549/549
(100 %)
0 diff
(100 %id)
BM562752 astrocytoma grade IV, cell line, brain .a 492 to 1391 1 to 902       902/1036
(87 %)
8 diff
(99.3 %id)
CN422237 embryonic stem cells, cell lines H1, H7, andH9 .a 501 to 1106 1 to 606       606/606
(100 %)
0 diff
(100 %id)
BQ051162 leiomyosarcoma, uterus .a 513 to 1256 1 to 748       748/1075
(69 %)
6 diff
(99.5 %id)
DR762481 embryonic stem .a 526 to 1340 1 to 815       815/815
(100 %)
0 diff
(100 %id)
CU455618 epidermis .a 550 to 1259 717 to 8     Submitted on the opposite strand 710/717
(99 %)
0 diff
(100 %id)
BI333528 cervical carcinoma cell line, cervix .a 555 to 1260 1 to 706       706/706
(100 %)
0 diff
(100 %id)
BI862287 breast, mammary adenocarcinoma, cell line .a 563 to 1353 1 to 793       793/795
(99 %)
13 diff
(98.4 %id)
BQ927555 carcinoma, cell line, Prostate .a 574 to 1389 1 to 821       821/914
(89 %)
10 diff
(99.0 %id)
CB409236 maxilla, pooled .a 638 to 1208 1 to 571       571/571
(100 %)
0 diff
(100 %id)
CB160825 Liver .a 655 to 1203 1 to 549       549/549
(100 %)
0 diff
(100 %id)
CR989763 T-Lymphocytes .a 660 to 1385 1 to 726       726/728
(99 %)
1 diff
(99.9 %id)
CU448900 epidermis .a 664 to 1259 603 to 8     Submitted on the opposite strand 596/603
(98 %)
3 diff
(99.6 %id)
CR976649 T-Lymphocytes .a 684 to 1498 1 to 813       813/819
(99 %)
4 diff
(99.6 %id)
CN422222 embryonic stem cells, cell lines H1, H7, andH9 .a 727 to 1443 1 to 716       716/721
(99 %)
3 diff
(99.6 %id)
CX872754 embryonic stem .a 770 to 1458 1 to 689       689/689
(100 %)
0 diff
(100 %id)
CD655191 Embryonic Stem cells .a 775 to 1485 1 to 713       713/805
(88 %)
6 diff
(99.3 %id)
BQ220432 embryonal carcinoma, cell line, testis .a 779 to 1653 1 to 877       877/884
(99 %)
8 diff
(99.1 %id)
CX754142 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 779 to 1442 1 to 664     Submitted on the opposite strand 664/664
(100 %)
1 diff
(99.9 %id)
CU451490 epidermis .a 784 to 1482 706 to 8     Submitted on the opposite strand 699/706
(99 %)
1 diff
(99.9 %id)
CU453037 epidermis .a 785 to 1482 706 to 9     Submitted on the opposite strand 698/706
(98 %)
2 diff
(99.8 %id)
BG032528 breast, mammary adenocarcinoma, cell line .a 819 to 1631 1 to 816       816/912
(89 %)
26 diff
(97.2 %id)
BG032366 breast, mammary adenocarcinoma, cell line .a 820 to 1500 1 to 681       681/968
(70 %)
9 diff
(99.1 %id)
CN422235 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 843 to 1453 1 to 611       611/611
(100 %)
0 diff
(100 %id)
CN422253 embryonic stem cells, cell lines H1, H7, andH9 .a 860 to 1533 1 to 674       674/674
(100 %)
0 diff
(100 %id)
DA736813   .a 917 to 1699 2 to 798   capped Submitted on the opposite strand 797/856
(93 %)
21 diff
(97.6 %id)
AI568428 anaplastic oligodendroglioma, brain .a 987 to 1472 486 to 1       486/486
(100 %)
0 diff
(100 %id)
BM905978 leiomyosarcoma, uterus .a 1064 to 2007 1 to 947       947/1053
(89 %)
17 diff
(98.4 %id)
DA207357 brain .a 1203 to 1787 2 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
DA904914   .a 1204 to 1766 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
BE883051 leiomyosarcoma, uterus .a 1207 to 1833 1 to 627       627/627
(100 %)
0 diff
(100 %id)
CN422174 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1215 to 1953 1 to 739       739/739
(100 %)
0 diff
(100 %id)
CU456321 epidermis .a 1235 to 1482 256 to 9     Submitted on the opposite strand 248/256
(96 %)
0 diff
(100 %id)
BF970505 adrenal cortex carcinoma, cell line, adrenal gland .a 1336 to 2101 1 to 768       768/1003
(76 %)
23 diff
(97.8 %id)
BI963106 Islets of Langerhans, Pancreas .a 1349 to 1905 1 to 557       557/557
(100 %)
0 diff
(100 %id)
DA603265   .a 1365 to 1934 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
BE767291 nervous_tumor .a 1369 to 1548 184 to 8       177/184
(96 %)
1 diff
(99.5 %id)
BM848232 myeloma .a 1620 to 2129 1 to 510       510/510
(100 %)
0 diff
(100 %id)
BM849417 myeloma .a 1620 to 2177 1 to 558   tiling clone,   558/558
(100 %)
0 diff
(100 %id)
BM846397 myeloma .a 1620 to 2144 1 to 525       525/525
(100 %)
0 diff
(100 %id)
CA495353   .a 1684 to 2564 1 to 888       888/892
(99 %)
12 diff
(98.7 %id)
CX784632 human embryonic stem cells .a 1693 to 2514 1 to 822       822/822
(100 %)
1 diff
(99.9 %id)
CR985984 T-Lymphocytes .a 1879 to 2722 1 to 845   tiling clone,   845/866
(97 %)
6 diff
(99.4 %id)
BQ278023 ovary, teratocarcinoma, cell line .a 2225 to 3213 1 to 1005       1005/1070
(93 %)
32 diff
(97.1 %id)
BU174047 ductal carcinoma, cell line, Pancreas .a 2280 to 3153 1 to 877       877/1049
(83 %)
14 diff
(98.7 %id)
CF137007 lymph .a 2369 to 2899 1 to 531       531/531
(100 %)
6 diff
(98.9 %id)
CN422239 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2399 to 2945 1 to 547       547/547
(100 %)
0 diff
(100 %id)
AL537834 brain, fetal brain .a 2445 to 3527 1062 to 1       1062/1066
(99 %)
26 diff
(97.6 %id)
AL046775 testis .a 2498 to 2987 1 to 490       490/490
(100 %)
0 diff
(100 %id)
AL527219 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 2512 to 3498 983 to 1       983/983
(100 %)
8 diff
(99.2 %id)
BE905137 epithelioid carcinoma, Pancreas .a 2513 to 3361 1 to 839       839/1035
(81 %)
48 diff
(95.4 %id)
BP424964 small intestine .a 2591 to 3113 1 to 523     Submitted on the opposite strand 523/523
(100 %)
0 diff
(100 %id)
CN422177 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2684 to 3369 1 to 687       687/687
(100 %)
1 diff
(99.9 %id)
BQ944271 carcinoma, cell line, Prostate .a 2686 to 3483 1 to 802   tiling clone,   802/884
(90 %)
7 diff
(99.3 %id)
CR743137 heart .a 2730 to 3292 1 to 563       563/563
(100 %)
0 diff
(100 %id)
CN422227 embryonic stem cells, cell lines H1, H7, andH9 .a 2841 to 3449 1 to 609       609/609
(100 %)
0 diff
(100 %id)
BU628884 cell lines, Chondrosarcoma .a 2905 to 3552 664 to 19   AAA Possibly primed on the genome, locally A rich (15/18 A in genome downstream of last aligned base) 646/646
(100 %)
2 diff
(99.7 %id)
AL043790 testis .a 2925 to 3518 594 to 1       594/594
(100 %)
0 diff
(100 %id)
BE858572 brain, glioblastoma (pooled) .a 2977 to 3448 472 to 1       472/472
(100 %)
0 diff
(100 %id)
AI857572 anaplastic oligodendroglioma, brain .a 3060 to 3552 493 to 1       493/493
(100 %)
0 diff
(100 %id)
AI201670 anaplastic oligodendroglioma, brain .a 3068 to 3552 485 to 1       485/485
(100 %)
0 diff
(100 %id)
BP394228 pancreatic islet .a 3072 to 3552 1 to 481     Submitted on the opposite strand 481/481
(100 %)
0 diff
(100 %id)
AI922096 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 3120 to 3498 379 to 1       379/379
(100 %)
0 diff
(100 %id)
AW572173 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 3131 to 3498 368 to 1       368/368
(100 %)
0 diff
(100 %id)
T30295 testis .a 3149 to 3359 1 to 211       211/211
(100 %)
0 diff
(100 %id)
BM480432 duodenal adenocarcinoma, cell line, small intestine .a 3159 to 4055 1 to 899       899/1003
(89 %)
19 diff
(98.2 %id)
AA658409   .a 3187 to 3552 378 to 14       365/378
(96 %)
0 diff
(100 %id)
BQ962113 epithelioid carcinoma cell line, Pancreas .a 3189 to 4013 1 to 835       835/839
(99 %)
10 diff
(98.9 %id)
AI768646 Kidney .a 3195 to 3406 229 to 18   AAA   212/212
(100 %)
0 diff
(100 %id)
BI754632 brain .a 3212 to 4065 1 to 850   tiling clone,   850/890
(95 %)
12 diff
(98.7 %id)
N63615 multiple sclerosis lesions .a 3226 to 3552 334 to 1       334/334
(100 %)
10 diff
(97.1 %id)
AA687187   .a 3235 to 3552 345 to 28       318/345
(92 %)
0 diff
(100 %id)
DB225938 trachea .a 3239 to 3800 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA752598   .a 3249 to 3815 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
CO250156 Chondrosarcoma Lung Metastasis cell lines, lung .a 3259 to 4021 8 to 758       751/817
(91 %)
13 diff
(98.5 %id)
BM828938 stomach .a 3261 to 3526 1 to 266       266/266
(100 %)
0 diff
(100 %id)
DA769302 brain .a 3264 to 3828 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA051818   .a 3301 to 3904 2 to 605   capped   604/604
(100 %)
0 diff
(100 %id)
CN422213 embryonic stem cells, DMSO-treated H9 cellline .a 3312 to 3826 1 to 515       515/515
(100 %)
0 diff
(100 %id)
DA482840   .a 3316 to 3896 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
DB151332 thymus .a 3319 to 3872 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
BP345909 synovial membrane .a 3331 to 3910 1 to 580       580/580
(100 %)
0 diff
(100 %id)
DA684722   .a 3332 to 3871 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
DA695159   .a 3332 to 3913 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
DA039640 bladder .a 3339 to 3911 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
FN177516 breast carcinoma .a 3363 to 3461 1 to 96       96/96
(100 %)
6 diff
(93.8 %id)
FN177382 breast carcinoma .a 3370 to 3461 11 to 103       93/104
(89 %)
3 diff
(97.2 %id)
BE779401 eye, retinoblastoma .a 3380 to 3548 1 to 169       169/169
(100 %)
0 diff
(100 %id)
CB409562 maxilla, pooled .a 3381 to 3552 1 to 172   AAA Possibly primed on the genome, locally A rich (15/18 A in genome downstream of last aligned base) 172/172
(100 %)
0 diff
(100 %id)
DA728404   .a 3416 to 4180 2 to 768   capped   767/767
(100 %)
5 diff
(99.4 %id)
BP302985   .a 3427 to 4008 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DA958845 Spleen .a 3427 to 3980 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA484779 brain .a 3430 to 3983 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA507639 brain .a 3430 to 4003 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA495298 brain .a 3433 to 3953 2 to 522   capped   521/521
(100 %)
0 diff
(100 %id)
BM474866 duodenal adenocarcinoma, cell line, small intestine .a 3434 to 4261 1 to 846       846/989
(85 %)
33 diff
(96.7 %id)
DA177904 amygdala .a 3436 to 4010 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DA067677 cerebellum .a 3443 to 4012 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA747945   .a 3443 to 3991 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DA792067 brain .a 3443 to 3930 2 to 489   capped   488/488
(100 %)
0 diff
(100 %id)
DA295709 hippocampus .a 3448 to 4023 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
BJ990848 hepatoblastoma .a 3448 to 4029 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BG340011 leiomyosarcoma cell line, uterus .a 3469 to 4014 1 to 546       546/555
(98 %)
0 diff
(100 %id)
DB257389 uterus .a 3485 to 4061 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DA776389 brain .a 3507 to 4086 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
DB248825 uterus .a 3517 to 4066 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA380957 thalamus .a 3518 to 4030 2 to 514   capped   513/513
(100 %)
0 diff
(100 %id)
DA619179   .a 3518 to 4061 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
BG260147 bladder, transitional cell papilloma, cell line .a 3531 to 4152 1 to 622       622/622
(100 %)
0 diff
(100 %id)
DA892107 rectum .a 3563 to 4123 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
AK023222   .a 3696 to 6103 1 to 2407   tiling clone, available from FLJ,   2407/2407
(100 %)
3 diff
(99.9 %id)
DA935389 Spleen .a 3702 to 4293 2 to 593   capped   592/592
(100 %)
0 diff
(100 %id)
CR992278 T-Lymphocytes .a 3732 to 4492 1 to 762   tiling clone,   762/762
(100 %)
2 diff
(99.8 %id)
DA931584 Spleen .a 3869 to 4416 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
BE791157 lung, small cell carcinoma .a 4185 to 4996 1 to 799       799/981
(81 %)
22 diff
(97.8 %id)
BQ063794 lymph, lymphoma, cell line .a 4250 to 5136 1 to 886       886/1051
(84 %)
34 diff
(96.8 %id)
BU540885 epithelioid carcinoma cell line, Pancreas .a 4253 to 5150 1 to 902       902/902
(100 %)
6 diff
(99.4 %id)
DB009138 colon, tumor tissue .a 4263 to 4822 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
CR996565 T-Lymphocytes .a 4278 to 4911 1 to 634       634/636
(99 %)
1 diff
(99.9 %id)
BQ637799 eye, retina .a 4282 to 4923 1 to 642       642/642
(100 %)
0 diff
(100 %id)
BP254407 Kidney .a 4348 to 4928 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BC003086 Brain, neuroblastoma .a 4426 to 6122 1 to 1697   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (15/18 A in genome downstream of last aligned base) 1697/1697
(100 %)
1 diff
(100.0 %id)
BU195308 eye, retinoblastoma .a 4464 to 5382 1 to 920       920/921
(99 %)
8 diff
(99.2 %id)
BC014221 Lung, small cell carcinoma .a 4477 to 6103 1 to 1627   available from MGC, AAA Possibly primed on the genome, locally A rich (15/18 A in genome downstream of last aligned base) 1627/1627
(100 %)
2 diff
(99.9 %id)
AK025821   .a 4522 to 6105 1 to 1584   available from FLJ, AAA Possibly primed on the genome, locally A rich (15/18 A in genome downstream of last aligned base) 1584/1584
(100 %)
1 diff
(100.0 %id)
AK000018 adipose tissue .a 4583 to 6105 221 to 1741   available from FLJ, AAA Possibly primed on the genome, locally A rich (15/18 A in genome downstream of last aligned base) 1521/1741
(87 %)
6 diff
(99.7 %id)
BQ221210 epithelioid carcinoma, Pancreas .a 4620 to 5428 1 to 818       818/923
(88 %)
24 diff
(97.4 %id)
CR995294 T-Lymphocytes .a 4676 to 5172 1 to 497       497/506
(98 %)
1 diff
(99.9 %id)
BQ920264 carcinoma, cell line, Prostate .a 4703 to 5588 1 to 891       891/896
(99 %)
9 diff
(99.0 %id)
BC018633 Pancreas, adenocarcinoma .a 4713 to 6122 1 to 1410   available from MGC, AAA Possibly primed on the genome, locally A rich (15/18 A in genome downstream of last aligned base) 1410/1410
(100 %)
1 diff
(100.0 %id)
CT002655 T-Lymphocytes .a 4721 to 5320 1 to 600       600/600
(100 %)
0 diff
(100 %id)
CR457223   .a 4745 to 5219 1 to 475       475/477
(99 %)
1 diff
(99.8 %id)
CD628360   .a 4747 to 5432 688 to 3       686/688
(99 %)
0 diff
(100 %id)
CD628362   .a 4749 to 5477 742 to 14       729/767
(95 %)
0 diff
(100 %id)
CA454089   .a 4753 to 5607 1 to 864       864/865
(99 %)
12 diff
(98.7 %id)
BI226145 Burkitt lymphoma, lymph .a 4809 to 5541 1 to 733       733/736
(99 %)
4 diff
(99.5 %id)
BU162473 melanotic melanoma, cell line, skin .a 4875 to 5728 1 to 861       861/901
(95 %)
23 diff
(97.5 %id)
BQ892883 melanotic melanoma, cell line, skin .a 4875 to 5727 1 to 858       858/858
(100 %)
6 diff
(99.4 %id)
BU184709 melanotic melanoma, cell line, skin .a 4875 to 5799 1 to 934       934/936
(99 %)
13 diff
(98.7 %id)
BQ681347 melanotic melanoma, cell line, skin .a 4875 to 5760 1 to 894       894/894
(100 %)
10 diff
(98.9 %id)
BQ681334 melanotic melanoma, cell line, skin .a 4875 to 5651 1 to 786       786/926
(84 %)
14 diff
(98.5 %id)
BU162985 melanotic melanoma, cell line, skin .a 4875 to 5704 1 to 838       838/933
(89 %)
18 diff
(98.1 %id)
BQ676077 melanotic melanoma, cell line, skin .a 4875 to 5751 1 to 880       880/880
(100 %)
8 diff
(99.1 %id)
CN333619 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 4932 to 5519 1 to 588       588/588
(100 %)
0 diff
(100 %id)
BU163225 melanotic melanoma, cell line, skin .a 5006 to 5854 1 to 863       863/926
(93 %)
34 diff
(96.4 %id)
BU196752 melanotic melanoma, cell line, skin .a 5006 to 5847 1 to 848       848/917
(92 %)
24 diff
(97.4 %id)
BQ676369 melanotic melanoma, cell line, skin .a 5006 to 5728 1 to 726       726/962
(75 %)
12 diff
(98.8 %id)
CV807234 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 5013 to 5749 1 to 737       737/737
(100 %)
1 diff
(99.9 %id)
CN333615 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 5131 to 5701 1 to 571       571/571
(100 %)
0 diff
(100 %id)
DR157031 human embryonic stem cells differentiated toan early endodermal cell type .a 5195 to 5850 1 to 656       656/656
(100 %)
2 diff
(99.7 %id)
FN071015 breast carcinoma .a 5495 to 5544 54 to 5     Submitted on the opposite strand 50/58
(86 %)
0 diff
(100 %id)
BJ990849 hepatoblastoma .a 5545 to 6084 540 to 1       540/540
(100 %)
1 diff
(99.9 %id)
BG938926 Bone, Hip .a 5595 to 6070 482 to 7       476/482
(98 %)
0 diff
(100 %id)
BQ187929 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 5600 to 6069 1 to 470       470/470
(100 %)
2 diff
(99.6 %id)
NM_012218.3   .b 1 to 6107 1 to 6107 exact RefSeq, AAA Possibly primed on the genome, locally A rich (15/18 A in genome downstream of last aligned base) 6107/6107
(100 %)
0 diff
(100 %id)
X98265 cervix .b 281 to 2151 173 to 2043   tiling clone,   1871/2043
(91 %)
9 diff
(99.6 %id)
AF167570   .b 318 to 3516 1 to 3200 G101C tiling clone, AAA Possibly primed on the genome, locally A rich (15/18 A in genome downstream of last aligned base) 3200/3200
(100 %)
3 diff
(100.0 %id)
BQ228750 embryonal carcinoma, cell line, testis .b 1056 to 1891 1 to 843       840/847
(99 %)
6 diff
(99.3 %id)
AJ271747   .b 1227 to 6090 1 to 4866   tiling clone,   4866/4866
(100 %)
2 diff
(100.0 %id)
CX756057 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 1261 to 1979 1 to 719       719/719
(100 %)
0 diff
(100 %id)
BE869944 adenocarcinoma, colon .b 1276 to 1980 1 to 706       706/1082
(65 %)
18 diff
(98.4 %id)
AL558474 T cells from T cell leukemia .b 1331 to 2296 1 to 954       954/963
(99 %)
14 diff
(98.6 %id)
TI_59391755   .b 1357 to 2164 83 to 891       809/934
(86 %)
20 diff
(97.9 %id)
BM013819 breast, mammary adenocarcinoma, cell line .b 1358 to 2164 1 to 808       808/834
(96 %)
20 diff
(97.7 %id)
BM460169 leiomyosarcoma, uterus .b 1396 to 2232 26 to 872       844/1138
(74 %)
31 diff
(97.3 %id)
TI_154160020   .b 1413 to 1963 86 to 636       551/555
(99 %)
5 diff
(99.1 %id)
CN422256 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 1430 to 1984 4 to 558       555/558
(99 %)
6 diff
(99.0 %id)
BQ216828 embryonal carcinoma, cell line, testis .b 1444 to 2004 1 to 563       563/1004
(56 %)
8 diff
(99.3 %id)
CN422184 embryonic stem cells, DMSO-treated H9 cellline .b 1469 to 2023 1 to 555       555/555
(100 %)
0 diff
(100 %id)
CV806794 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 1517 to 2317 1 to 805       805/895
(89 %)
20 diff
(97.8 %id)
BU182231 eye, retinoblastoma .b 1520 to 2086 24 to 598       575/985
(58 %)
27 diff
(97.3 %id)
BM458264 lymph, lymphoma, cell line .b 1528 to 2324 1 to 801       801/1163
(68 %)
7 diff
(99.4 %id)
CR994612 T-Lymphocytes .b 1530 to 2167 1 to 639       639/660
(96 %)
3 diff
(99.6 %id)
DA985526 synovial membrane tissue from rheumatioidarthritis .b 1586 to 2150 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA354495 substantia nigra .b 1671 to 2251 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
CD252620 White Matter .b 1679 to 2118 67 to 507       441/1161
(37 %)
14 diff
(98.8 %id)
DA003518   .b 1705 to 2275 2 to 570   capped   569/569
(100 %)
2 diff
(99.7 %id)
BF355942 head_neck .b 1707 to 1910 6 to 210       205/210
(97 %)
8 diff
(96.2 %id)
BF316461 brain, neuroblastoma .b 1727 to 2382 1 to 651       653/705
(92 %)
14 diff
(98.1 %id)
CR985677 T-Lymphocytes .b 1734 to 2505 1 to 773       773/776
(99 %)
4 diff
(99.5 %id)
TI_57219016   .b 1742 to 2669 50 to 969       920/993
(92 %)
23 diff
(97.7 %id)
BI753898 brain .b 1751 to 2669 1 to 912       912/936
(97 %)
18 diff
(98.1 %id)
BE876294 large cell carcinoma, undifferentiated, lung .b 1804 to 2604 1 to 795       795/833
(95 %)
16 diff
(98.1 %id)
AL580290 T cells from T cell leukemia .b 2577 to 3502 916 to 1       916/955
(95 %)
23 diff
(97.6 %id)
NM_001137673.1   .c 1 to 3740 1 to 3740 exact RefSeq, AAA   3740/3740
(100 %)
0 diff
(100 %id)
BC064836 Uterus, leiomyosarcoma .c 68 to 3736 1 to 3668 exact tiling clone, available from MGC, AAA   3668/3668
(100 %)
2 diff
(100.0 %id)
AK291617 placenta .c 116 to 2572 1 to 2457 exact     2457/2457
(100 %)
1 diff
(100.0 %id)
AL520755 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .c 120 to 1021 1 to 902       902/902
(100 %)
0 diff
(100 %id)
AW503711 lymph .c 125 to 622 8 to 505       498/505
(98 %)
6 diff
(98.9 %id)
AU135886 placenta .c 279 to 1032 2 to 761   capped   758/760
(99 %)
6 diff
(99.3 %id)
BU786326 Pancreas, Purified pancreatic islet .c 783 to 1391 1 to 608       608/626
(97 %)
7 diff
(98.9 %id)
AA075940   .c 789 to 875 1 to 87       87/87
(100 %)
0 diff
(100 %id)
AU130139   .c 1012 to 1780 2 to 773   capped   772/773
(99 %)
8 diff
(99.0 %id)
DA734688   .c 1117 to 1766 2 to 653   capped   652/730
(89 %)
14 diff
(98.1 %id)
AA280961 germinal center B cell .c 1228 to 1707 1 to 473       477/474
(100 %)
16 diff
(96.7 %id)
TI_1948231317   .c 1466 to 2437 1112 to 130       983/1439
(68 %)
27 diff
(98.2 %id)
CN422163 embryonic stem cells, cell lines H1, H7, andH9 .c 1876 to 2637 12 to 773       762/773
(98 %)
7 diff
(99.1 %id)
CX752434 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 1957 to 2678 1 to 717     Submitted on the opposite strand 717/817
(87 %)
10 diff
(98.8 %id)
BF969241 adrenal cortex carcinoma, cell line, adrenal gland .c 2023 to 2861 1 to 845       845/868
(97 %)
29 diff
(96.7 %id)
TI_57230501   .c 2054 to 2612 56 to 618       563/852
(66 %)
10 diff
(98.9 %id)
F12857 brain, total brain .c 2057 to 2360 1 to 303       303/303
(100 %)
3 diff
(99.1 %id)
F13377 brain, total brain .c 2057 to 2332 1 to 276       276/276
(100 %)
4 diff
(98.6 %id)
CV572117 cornea, eye .c 2057 to 2678 1 to 622       622/622
(100 %)
1 diff
(99.9 %id)
CN422226 embryonic stem cells, cell lines H1, H7, andH9 .c 2058 to 2818 1 to 761       761/761
(100 %)
3 diff
(99.7 %id)
BE545201 cervical carcinoma cell line, cervix .c 2066 to 2742 1 to 676       676/685
(98 %)
15 diff
(97.9 %id)
AF007140 brain .c 2088 to 3736 1 to 1649   AAA   1649/1649
(100 %)
1 diff
(100.0 %id)
DA747657   .c 2095 to 2666 2 to 574   capped   573/573
(100 %)
2 diff
(99.7 %id)
W79824 heart .c 2101 to 2558 1 to 461       461/461
(100 %)
10 diff
(97.9 %id)
CR618513 Neuroblastoma Cot 25-normalized .c 2126 to 3709 1 to 1584   tiling clone,   1584/1584
(100 %)
0 diff
(100 %id)
BX354326 Neuroblastoma Cot 25-normalized .c 2126 to 3084 1 to 951   fully sequenced,   951/951
(100 %)
2 diff
(99.8 %id)
BQ440004 melanotic melanoma, skin .c 2135 to 2881 1 to 752       752/854
(88 %)
15 diff
(98.3 %id)
DB488711 hypothalamus .c 2144 to 2600 1 to 456       456/456
(100 %)
2 diff
(99.6 %id)
DB444319 testis .c 2157 to 2613 1 to 457       457/457
(100 %)
3 diff
(99.4 %id)
BM479450 eye, retinoblastoma .c 2200 to 3200 1 to 1012       1012/1033
(97 %)
26 diff
(97.5 %id)
BG177834 lymph, lymphoma, cell line .c 2234 to 2942 1 to 707       707/1019
(69 %)
16 diff
(98.5 %id)
BY996052   .c 2269 to 2920 10 to 661       652/661
(98 %)
10 diff
(98.5 %id)
CN422197 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 2295 to 2828 1 to 534       534/534
(100 %)
1 diff
(99.9 %id)
CN422252 embryonic stem cells, DMSO-treated H9 cellline .c 2315 to 2784 1 to 470       470/470
(100 %)
1 diff
(99.8 %id)
BF690686 melanotic melanoma, high MDR, skin .c 2324 to 3005 1 to 668       668/850
(78 %)
15 diff
(98.3 %id)
AA297766   .c 2332 to 2636 1 to 304       304/304
(100 %)
2 diff
(99.4 %id)
CN422175 embryonic stem cells, DMSO-treated H9 cellline .c 2336 to 2859 1 to 524       524/524
(100 %)
4 diff
(99.3 %id)
BG435212 placenta .c 2337 to 2966 1 to 628       628/997
(62 %)
14 diff
(98.6 %id)
CX787020 human embryonic stem cells .c 2366 to 3114 1 to 749       749/749
(100 %)
1 diff
(99.9 %id)
BX340875.
matches multiple genes
  .c 2389 to 3256 1 to 872     also hits gene AK3L2 872/872
(100 %)
14 diff
(98.4 %id)
BP196669 adrenal gland .c 2419 to 3001 1 to 582       582/582
(100 %)
4 diff
(99.4 %id)
DB491508 hypothalamus .c 2428 to 2836 1 to 411       411/411
(100 %)
2 diff
(99.6 %id)
CX867585 embryonic stem .c 2434 to 3188 1 to 755   fully sequenced,   755/755
(100 %)
0 diff
(100 %id)
BM699013 eye, fetal eyes .c 2434 to 2929 1 to 497       497/497
(100 %)
3 diff
(99.4 %id)
CD673098 eye, Iris .c 2458 to 3013 1 to 556       556/556
(100 %)
1 diff
(99.9 %id)
AV764023 bone marrow .c 2458 to 3200 1 to 732       732/734
(99 %)
17 diff
(97.7 %id)
CN422201 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 2466 to 2768 1 to 303       303/303
(100 %)
2 diff
(99.4 %id)
CD671263 eye, Iris .c 2486 to 3107 1 to 622       622/622
(100 %)
0 diff
(100 %id)
CN422234 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 2488 to 3077 1 to 592       592/592
(100 %)
2 diff
(99.7 %id)
AA188883   .c 2488 to 2954 1 to 467       467/467
(100 %)
11 diff
(97.7 %id)
CA388659 eye, RPE/choroid .c 2508 to 2955 1 to 449       449/449
(100 %)
1 diff
(99.8 %id)
BE827606 lung_tumor .c 2521 to 2918 403 to 5       399/403
(99 %)
0 diff
(100 %id)
CV412574 lung_tumor .c 2521 to 2856 342 to 2     Submitted on the opposite strand 341/342
(99 %)
0 diff
(100 %id)
T09042   .c 2521 to 2955 438 to 1     Submitted on the opposite strand 438/438
(100 %)
7 diff
(98.5 %id)
CN422221 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 2522 to 3050 1 to 529       529/529
(100 %)
0 diff
(100 %id)
BF969530 adrenal cortex carcinoma, cell line, adrenal gland .c 2531 to 3218 1 to 691       691/729
(94 %)
17 diff
(97.7 %id)
BG527891 lung, mucoepidermoid carcinoma .c 2536 to 3222 1 to 680       680/727
(93 %)
20 diff
(97.3 %id)
CR620107 Neuroblastoma Cot 25-normalized .c 2552 to 3714 1 to 1163       1163/1163
(100 %)
0 diff
(100 %id)
BX376195 Neuroblastoma Cot 25-normalized .c 2552 to 3560 1 to 986       986/989
(99 %)
27 diff
(97.3 %id)
N45029 melanocyte .c 2565 to 2767 1 to 213       213/214
(99 %)
15 diff
(93.0 %id)
CB138459 Liver .c 2591 to 3208 1 to 617       617/617
(100 %)
1 diff
(99.9 %id)
N28825 melanocyte .c 2666 to 3257 1 to 611       611/618
(98 %)
30 diff
(95.2 %id)
CN422200 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 2697 to 3374 1 to 678       678/678
(100 %)
1 diff
(99.9 %id)
BG284163 adenocarcinoma, cell line, Prostate .c 2697 to 3297 1 to 597       597/597
(100 %)
5 diff
(99.2 %id)
W28097 eye, retina .c 2702 to 3148 467 to 21       447/471
(94 %)
0 diff
(100 %id)
BG026289 Bone, osteosarcoma, cell line .c 2708 to 3374 1 to 666       666/901
(73 %)
12 diff
(98.7 %id)
TI_149286905   .c 2727 to 3736 1048 to 58   AAA   991/1201
(82 %)
60 diff
(95.1 %id)
BG119672 adenocarcinoma, cell line, Liver .c 2734 to 3571 1 to 848       848/1105
(76 %)
36 diff
(96.8 %id)
BF356364 head_neck .c 2736 to 2878 1 to 143       143/143
(100 %)
0 diff
(100 %id)
BF356306 head_neck .c 2737 to 3191 457 to 4       454/457
(99 %)
0 diff
(100 %id)
BF356326 head_neck .c 2737 to 2877 156 to 18       139/156
(89 %)
0 diff
(100 %id)
BF356331 head_neck .c 2737 to 2884 148 to 2       147/148
(99 %)
0 diff
(100 %id)
BF380183 uterus_tumor .c 2737 to 2872 139 to 5       135/139
(97 %)
0 diff
(100 %id)
FN144361 breast carcinoma .c 2740 to 2864 133 to 1     Submitted on the opposite strand 133/139
(95 %)
8 diff
(94.3 %id)
BE785446 large cell carcinoma, lung .c 2751 to 3497 11 to 767       757/1049
(72 %)
40 diff
(96.2 %id)
AL520754 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .c 2755 to 3721 968 to 1       968/968
(100 %)
4 diff
(99.6 %id)
CN422230 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 2763 to 3369 8 to 614       607/614
(98 %)
6 diff
(99.1 %id)
FN093703 breast carcinoma .c 2779 to 2889 123 to 11     Submitted on the opposite strand 113/123
(91 %)
0 diff
(100 %id)
CN422216 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 2792 to 3064 1 to 273       273/273
(100 %)
4 diff
(98.6 %id)
BF356333 head_neck .c 2793 to 3199 410 to 3       408/410
(99 %)
0 diff
(100 %id)
CN422161 embryonic stem cells, DMSO-treated H9 cellline .c 2802 to 2930 1 to 129       129/129
(100 %)
1 diff
(99.3 %id)
BG285959 bladder, transitional cell papilloma, cell line .c 2825 to 3590 1 to 761       761/955
(79 %)
42 diff
(95.7 %id)
BG285904 bladder, transitional cell papilloma, cell line .c 2825 to 3602 1 to 768       768/774
(99 %)
32 diff
(95.9 %id)
CB267360 adipose .c 2851 to 3314 1 to 464       464/465
(99 %)
1 diff
(99.8 %id)
CK430058 eye, lacrimal gland .c 2863 to 3500 1 to 638       638/638
(100 %)
0 diff
(100 %id)
CN422233 embryonic stem cells, cell lines H1, H7, andH9 .c 2873 to 3470 1 to 598       598/598
(100 %)
0 diff
(100 %id)
AA911536 carcinoid, lung .c 2894 to 3240 347 to 1       347/347
(100 %)
0 diff
(100 %id)
CN422183 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 2903 to 3286 8 to 392       385/392
(98 %)
6 diff
(98.5 %id)
AW467096 2 pooled tumors (clear cell type), Kidney .c 2911 to 3245 337 to 3       335/337
(99 %)
0 diff
(100 %id)
BE542816 cervix .c 2964 to 3622 1 to 650       650/730
(89 %)
19 diff
(97.4 %id)
AA036842 uterus .c 2969 to 3400 1 to 437       437/437
(100 %)
8 diff
(98.2 %id)
FN118482 breast carcinoma .c 2972 to 3043 1 to 72       72/73
(98 %)
1 diff
(98.7 %id)
FN059163 breast carcinoma .c 2981 to 3045 66 to 1     Submitted on the opposite strand 66/66
(100 %)
2 diff
(97.0 %id)
CN422178 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 2993 to 3516 1 to 524       524/524
(100 %)
0 diff
(100 %id)
CN422220 embryonic stem cells, cell lines H1, H7, andH9 .c 3004 to 3434 1 to 432       432/432
(100 %)
4 diff
(99.1 %id)
AW842359 colon_normal .c 3017 to 3367 368 to 19       350/376
(93 %)
0 diff
(100 %id)
BF988003 placenta_normal .c 3044 to 3480 441 to 1       441/472
(93 %)
0 diff
(100 %id)
BX354325 Neuroblastoma Cot 25-normalized .c 3054 to 3709 646 to 1   fully sequenced,   646/646
(100 %)
6 diff
(99.1 %id)
AA373328 lung .c 3071 to 3251 1 to 182       182/182
(100 %)
1 diff
(99.5 %id)
AU152157   .c 3075 to 3597 525 to 1       525/552
(95 %)
8 diff
(98.6 %id)
BF987797 placenta_normal .c 3087 to 3491 420 to 1       420/420
(100 %)
18 diff
(95.8 %id)
BU737455 eye, fetal eyes .c 3101 to 3736 651 to 16   AAA   636/636
(100 %)
0 diff
(100 %id)
BM797995 Ascites, stomach .c 3139 to 3558 1 to 420       420/420
(100 %)
0 diff
(100 %id)
BF976758 B-cells, primary B-cells from tonsils (cell line) .c 3150 to 3588 1 to 439   AAA   439/439
(100 %)
1 diff
(99.8 %id)
BG398366 B-cells, primary B-cells from tonsils (cell line) .c 3150 to 3588 1 to 436   AAA   436/436
(100 %)
3 diff
(99.4 %id)
CX867502 embryonic stem .c 3158 to 3736 604 to 26   fully sequenced, AAA   579/579
(100 %)
5 diff
(99.2 %id)
AW293293   .c 3165 to 3425 14 to 274     Submitted on the opposite strand 261/274
(95 %)
1 diff
(99.7 %id)
BU784599 Pancreas, Purified pancreatic islet .c 3188 to 3736 559 to 11   AAA   549/549
(100 %)
2 diff
(99.7 %id)
AW576353 lymph .c 3203 to 3740 555 to 18   AAA   538/538
(100 %)
0 diff
(100 %id)
CA311268 Human Lung Epithelial cells, lung .c 3207 to 3480 1 to 272     Submitted on the opposite strand 272/278
(97 %)
5 diff
(98.3 %id)
GD150148   .c 3220 to 3548 328 to 1     Submitted on the opposite strand 328/337
(97 %)
5 diff
(98.6 %id)
AU151634   .c 3241 to 3736 496 to 1       496/496
(100 %)
4 diff
(99.2 %id)
DB374275 placenta .c 3250 to 3736 482 to 1       482/493
(97 %)
18 diff
(96.4 %id)
FN140826 breast carcinoma .c 3262 to 3360 94 to 1     Submitted on the opposite strand 94/94
(100 %)
8 diff
(91.5 %id)
N23353 melanocyte .c 3279 to 3740 465 to 1       465/466
(99 %)
4 diff
(99.2 %id)
AL555418 placenta .c 3280 to 3689 499 to 905       578/908
(63 %)
27 diff
(97.1 %id)
AA280881 germinal center B cell .c 3286 to 3736 451 to 1       451/451
(100 %)
0 diff
(100 %id)
W78117 heart .c 3309 to 3736 428 to 1       428/428
(100 %)
0 diff
(100 %id)
N35021 melanocyte .c 3311 to 3736 426 to 1       426/428
(99 %)
0 diff
(100 %id)
AA074284   .c 3337 to 3697 365 to 1       365/365
(100 %)
4 diff
(99.0 %id)
AA188822   .c 3373 to 3737 374 to 1       374/429
(87 %)
13 diff
(97.0 %id)
FN099400 breast carcinoma .c 3422 to 3526 1 to 103       103/103
(100 %)
2 diff
(98.1 %id)
F10457 brain, total brain .c 3435 to 3736 302 to 1       302/302
(100 %)
0 diff
(100 %id)
BE162734 head_neck .c 3438 to 3554 118 to 1     Submitted on the opposite strand 118/118
(100 %)
3 diff
(97.5 %id)
F10968 brain, total brain .c 3440 to 3736 297 to 1       297/297
(100 %)
1 diff
(99.7 %id)
NM_004516.3   .d 1 to 3728 1 to 3728 exact RefSeq, AAA   3728/3728
(100 %)
0 diff
(100 %id)
AK291205   .d 101 to 2722 1 to 2621 I146M tiling clone,   2621/2621
(100 %)
3 diff
(99.9 %id)
AJ271745   .d 229 to 3726 1 to 3498 exact tiling clone,   3498/3498
(100 %)
1 diff
(100.0 %id)
AF147209   .d 306 to 3435 1 to 3128 G260V S647T     3128/3128
(100 %)
31 diff
(99.1 %id)
AF167569   .d 318 to 3721 1 to 3404 G101C AAA   3404/3404
(100 %)
2 diff
(100.0 %id)
AU137647 placenta .d 1407 to 2168 2 to 771   capped   770/841
(91 %)
16 diff
(98.1 %id)
DA832987 placenta .d 1648 to 2493 2 to 864   capped   861/863
(99 %)
28 diff
(96.8 %id)
DA735969   .d 1663 to 2472 2 to 819   capped   818/861
(95 %)
23 diff
(97.4 %id)
BE735126 choriocarcinoma, placenta .d 1698 to 2523 42 to 864   tiling clone,   823/864
(95 %)
19 diff
(97.9 %id)
BG256276 adenocarcinoma, cell line, Prostate .d 1781 to 2552 1 to 762       762/940
(81 %)
20 diff
(97.9 %id)
BU508156 leiomyosarcoma, uterus .d 1790 to 2545 1 to 761       761/1364
(55 %)
19 diff
(98.7 %id)
CX788296 human embryonic stem cells .d 1804 to 2611 18 to 825       808/825
(97 %)
7 diff
(99.2 %id)
AU157247 placenta .d 2500 to 2992 490 to 1       490/490
(100 %)
8 diff
(98.4 %id)
AU153072   .d 3194 to 3724 529 to 1       529/532
(99 %)
9 diff
(98.4 %id)
NM_153464.2   .e 1 to 3285 1 to 3285 exact RefSeq, AAA   3285/3285
(100 %)
0 diff
(100 %id)
AJ271746   .e 249 to 3283 1 to 3035 exact tiling clone,   3035/3035
(100 %)
1 diff
(100.0 %id)
AA158067 Pancreas .e 1715 to 2194 1 to 480       480/480
(100 %)
7 diff
(98.6 %id)
BF527902 anaplastic oligodendroglioma with 1p/19qloss, brain .e 2127 to 2916 1 to 784   tiling clone,   784/868
(90 %)
33 diff
(96.2 %id)
AA157449 Pancreas .e 2865 to 3286 424 to 3       422/424
(99 %)
0 diff
(100 %id)
CB123810 Liver .e 3189 to 3284 98 to 4   tiling clone, Submitted on the opposite strand 95/117
(81 %)
0 diff
(100 %id)
AJ271744   .f 1 to 3466 1 to 3467 exact tiling clone,   3467/3467
(100 %)
6 diff
(99.9 %id)
AU135960 placenta .f 991 to 1737 2 to 747   capped   746/750
(99 %)
12 diff
(98.4 %id)
TI_149286922   .f 2582 to 3467 953 to 88   AAA   866/1075
(80 %)
20 diff
(98.2 %id)
TI_149290229   .f 2656 to 3468 880 to 84   AAA   797/800
(99 %)
20 diff
(97.5 %id)
TI_154102597   .f 2667 to 3464 869 to 81   AAA   789/794
(99 %)
12 diff
(98.5 %id)
BG253725 adenocarcinoma, cell line, Prostate .f 2679 to 3467 5 to 790       786/945
(83 %)
6 diff
(99.4 %id)
W67334 heart .f 2709 to 2947 1 to 239       239/240
(99 %)
2 diff
(99.2 %id)
TI_149293049   .f 2709 to 3464 821 to 76   AAA   746/796
(93 %)
15 diff
(98.2 %id)
AA040497 heart .f 2732 to 3042 1 to 312       312/312
(100 %)
1 diff
(99.7 %id)
TI_154119715   .f 2734 to 3464 795 to 80   AAA   716/923
(77 %)
48 diff
(94.8 %id)
CR614313 neuroblastoma .f 2735 to 3466 1 to 732       732/732
(100 %)
0 diff
(100 %id)
BX457924 neuroblastoma .f 2735 to 3466 1 to 732       732/732
(100 %)
1 diff
(99.9 %id)
BM972252 lung .f 2753 to 3467 728 to 16   AAA   713/715
(99 %)
4 diff
(99.5 %id)
BM712216 eye, lens .f 2760 to 3028 1 to 269   fully sequenced,   269/269
(100 %)
1 diff
(99.7 %id)
CB048817 Prostate .f 2776 to 3466 1 to 691   fully sequenced,   691/691
(100 %)
6 diff
(99.2 %id)
BU625854 cell lines, Enchondroma .f 2793 to 3467 690 to 16   AAA   675/675
(100 %)
1 diff
(99.9 %id)
BM973331 lung .f 2798 to 3468 688 to 19   AAA   670/673
(99 %)
1 diff
(99.9 %id)
BQ015546 Chondrosarcoma, Left Pelvis .f 2799 to 3464 680 to 16   AAA   665/665
(100 %)
1 diff
(99.9 %id)
CA428486 cell lines, Chondrosarcoma .f 2809 to 3464 671 to 16   AAA   656/656
(100 %)
0 diff
(100 %id)
BU625953 cell lines, Enchondroma .f 2809 to 3467 674 to 16   AAA   659/659
(100 %)
1 diff
(99.9 %id)
TI_154134142   .f 2812 to 3468 766 to 104   AAA   663/1061
(62 %)
11 diff
(99.0 %id)
BM972314 lung .f 2816 to 3464 662 to 16   AAA   647/647
(100 %)
4 diff
(99.4 %id)
BU633467 cell lines, Chondrosarcoma .f 2849 to 3464 631 to 16   AAA   616/616
(100 %)
4 diff
(99.4 %id)
TI_154145141   .f 2856 to 3464 705 to 93   AAA Submitted on the opposite strand 613/613
(100 %)
16 diff
(97.4 %id)
BG939620 bone marrow stroma .f 2862 to 3464 622 to 20   AAA   603/603
(100 %)
1 diff
(99.9 %id)
AI910879 pooled .f 2896 to 3465 570 to 1       570/570
(100 %)
0 diff
(100 %id)
AI810023 pooled .f 2896 to 3464 569 to 1       569/569
(100 %)
0 diff
(100 %id)
TI_157609564   .f 2901 to 3468 655 to 88   AAA   568/569
(99 %)
1 diff
(99.9 %id)
AW051747 Kidney .f 2910 to 3465 556 to 1       556/556
(100 %)
0 diff
(100 %id)
AI933289 anaplastic oligodendroglioma, brain .f 2915 to 3464 551 to 1       551/551
(100 %)
3 diff
(99.5 %id)
BE646523 B-cell, chronic lymphotic leukemia .f 2924 to 3467 552 to 9       544/552
(98 %)
0 diff
(100 %id)
BU739294 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .f 2933 to 3464 1 to 529     Submitted on the opposite strand 529/538
(98 %)
3 diff
(99.5 %id)
BE856959 pooled .f 2935 to 3464 542 to 13   AAA   530/530
(100 %)
1 diff
(99.9 %id)
BM714664 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .f 2937 to 3464 528 to 1     Submitted on the opposite strand 528/537
(98 %)
1 diff
(99.9 %id)
AW001341 colon, colonic mucosa from 3 patients with Crohn'sdisease .f 2940 to 3468 529 to 1       529/529
(100 %)
0 diff
(100 %id)
AI652098 pooled germ cell tumors .f 2948 to 3462 515 to 2       514/515
(99 %)
0 diff
(100 %id)
H27016 breast .f 2958 to 3393 1 to 439       439/441
(99 %)
7 diff
(98.5 %id)
CF529896 placenta .f 2962 to 3468 525 to 19   AAA   507/507
(100 %)
0 diff
(100 %id)
AI159935 heart .f 2963 to 3466 504 to 1       504/504
(100 %)
0 diff
(100 %id)
AI638606 pooled germ cell tumors .f 2964 to 3464 501 to 1       501/501
(100 %)
0 diff
(100 %id)
AW474524 serous papillary carcinoma, high grade, 2pooled tumors, uterus .f 2972 to 3465 494 to 1       494/494
(100 %)
0 diff
(100 %id)
AA309884   .f 2976 to 3357 1 to 383       383/383
(100 %)
2 diff
(99.5 %id)
CB159611 Liver .f 2978 to 3464 497 to 15   AAA Submitted on the opposite strand 483/486
(99 %)
4 diff
(99.2 %id)
DB567167 hypothalamus .f 2989 to 3468 1 to 479     Submitted on the opposite strand 479/479
(100 %)
1 diff
(99.8 %id)
BQ015641 placenta .f 2990 to 3468 496 to 18   AAA   479/479
(100 %)
0 diff
(100 %id)
AI123703 pooled .f 2993 to 3466 478 to 5       474/478
(99 %)
0 diff
(100 %id)
AI554896 pooled .f 2993 to 3465 473 to 1       473/473
(100 %)
0 diff
(100 %id)
BM272937 insulinoma, Pancreas .f 2994 to 3464 478 to 8     Submitted on the opposite strand 471/478
(98 %)
0 diff
(100 %id)
AI808023 pooled .f 2994 to 3448 455 to 1       455/455
(100 %)
7 diff
(98.5 %id)
N93751 lung .f 2996 to 3465 468 to 1       468/468
(100 %)
1 diff
(99.8 %id)
BM670276 eye, lens .f 2998 to 3464 482 to 16   fully sequenced, AAA   467/467
(100 %)
2 diff
(99.6 %id)
AI523457 aorta .f 3004 to 3461 458 to 1       458/458
(100 %)
1 diff
(99.8 %id)
W67224 heart .f 3014 to 3465 452 to 1       452/452
(100 %)
0 diff
(100 %id)
DB558072 hypothalamus .f 3022 to 3464 1 to 442     Submitted on the opposite strand 442/442
(100 %)
1 diff
(99.8 %id)
AA833940 Kidney, kidney tumor .f 3027 to 3421 395 to 1       395/395
(100 %)
0 diff
(100 %id)
AI754219 bone marrow stroma .f 3029 to 3468 466 to 27   AAA   440/440
(100 %)
0 diff
(100 %id)
AW169415 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .f 3031 to 3466 438 to 3       436/438
(99 %)
0 diff
(100 %id)
AI499661 anaplastic oligodendroglioma, brain .f 3040 to 3464 424 to 1       424/424
(100 %)
3 diff
(99.3 %id)
AI679698 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .f 3040 to 3464 426 to 1       426/426
(100 %)
1 diff
(99.8 %id)
AI679123 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .f 3041 to 3464 426 to 1       426/426
(100 %)
2 diff
(99.6 %id)
AA040393 heart .f 3042 to 3464 442 to 19   AAA   424/430
(98 %)
1 diff
(99.8 %id)
AI082863   .f 3042 to 3466 432 to 8       425/432
(98 %)
0 diff
(100 %id)
AI086826 senescent fibroblast .f 3042 to 3468 433 to 7       427/433
(98 %)
0 diff
(100 %id)
AI146620 senescent fibroblast .f 3042 to 3466 430 to 6       425/430
(98 %)
0 diff
(100 %id)
AI554324 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .f 3043 to 3464 438 to 16   AAA   423/423
(100 %)
2 diff
(99.6 %id)
AI264156 Kidney .f 3044 to 3466 426 to 4       423/426
(99 %)
0 diff
(100 %id)
AA805432 germinal center B cell .f 3047 to 3466 424 to 5       420/424
(99 %)
0 diff
(100 %id)
DB562021 hypothalamus .f 3048 to 3468 1 to 422     Submitted on the opposite strand 422/422
(100 %)
4 diff
(99.1 %id)
R09770 liver and spleen .f 3048 to 3347 1 to 310   fully sequenced,   310/310
(100 %)
9 diff
(97.1 %id)
AI094441 pooled .f 3048 to 3464 417 to 1       417/417
(100 %)
0 diff
(100 %id)
BF530144 anaplastic oligodendroglioma with 1p/19qloss, brain .f 3049 to 3464 1 to 417   AAA   417/417
(100 %)
2 diff
(99.6 %id)
BX100848 liver and spleen .f 3052 to 3464 1 to 414   AAA   414/414
(100 %)
1 diff
(99.8 %id)
AA831736 germinal center B cell .f 3063 to 3464 412 to 11   AAA   402/402
(100 %)
0 diff
(100 %id)
AA834312 epithelium (cell line), Prostate .f 3063 to 3421 358 to 1       358/358
(100 %)
2 diff
(99.5 %id)
AW474482 serous papillary carcinoma, high grade, 2pooled tumors, uterus .f 3066 to 3465 400 to 1       400/400
(100 %)
2 diff
(99.5 %id)
AA708625 uterus .f 3068 to 3464 397 to 1       397/397
(100 %)
1 diff
(99.8 %id)
AI208808   .f 3070 to 3468 402 to 4       399/402
(99 %)
0 diff
(100 %id)
BF197774 skin, normal, 4 pooled samples .f 3071 to 3468 398 to 1       398/398
(100 %)
0 diff
(100 %id)
AI261260 adenocarcinoma, colon .f 3081 to 3467 387 to 1       387/387
(100 %)
0 diff
(100 %id)
AA826208 germinal center B cell .f 3084 to 3467 414 to 31   AAA   384/384
(100 %)
3 diff
(99.3 %id)
AA923731 pooled .f 3097 to 3466 376 to 7       370/376
(98 %)
0 diff
(100 %id)
AA888244 metastatic prostate bone lesion .f 3098 to 3469 385 to 15   AAA   371/371
(100 %)
2 diff
(99.5 %id)
AA918643 Kidney .f 3099 to 3466 369 to 2       368/369
(99 %)
0 diff
(100 %id)
AU156392 placenta .f 3104 to 3464 359 to 1       359/359
(100 %)
5 diff
(98.7 %id)
AI918431 adenocarcinoma, Pancreas .f 3109 to 3468 360 to 1       360/360
(100 %)
0 diff
(100 %id)
AW407248 lymph .f 3109 to 3464 377 to 22   AAA Submitted on the opposite strand 356/356
(100 %)
1 diff
(99.8 %id)
BE644678 pooled .f 3129 to 3472 358 to 14   AAA   345/345
(100 %)
2 diff
(99.5 %id)
AW182680 pooled .f 3130 to 3465 336 to 1       336/336
(100 %)
3 diff
(99.2 %id)
AW467584 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .f 3130 to 3468 357 to 19   AAA   339/339
(100 %)
4 diff
(98.9 %id)
BF058367 fibrotheoma, ovary .f 3130 to 3468 340 to 2       339/340
(99 %)
0 diff
(100 %id)
BG056858 anaplastic oligodendroglioma, brain .f 3130 to 3468 352 to 14   AAA   339/339
(100 %)
5 diff
(98.6 %id)
AI914458 pooled .f 3133 to 3464 332 to 1       332/332
(100 %)
2 diff
(99.4 %id)
AI262646 adenocarcinoma, colon .f 3146 to 3467 322 to 1       322/322
(100 %)
0 diff
(100 %id)
N52865 multiple sclerosis lesions .f 3148 to 3461 314 to 1       314/314
(100 %)
0 diff
(100 %id)
AA928002 pooled .f 3151 to 3465 315 to 1       315/315
(100 %)
0 diff
(100 %id)
AA927078 pooled .f 3162 to 3467 309 to 4       306/309
(99 %)
0 diff
(100 %id)
AI365404 B-cell, chronic lymphotic leukemia .f 3165 to 3467 308 to 6       303/308
(98 %)
0 diff
(100 %id)
AA905418 pooled .f 3174 to 3464 291 to 1       291/291
(100 %)
1 diff
(99.7 %id)
D20198   .f 3180 to 3468 1 to 290     Submitted on the opposite strand 290/293
(98 %)
3 diff
(99.0 %id)
AA922815 pooled germ cell tumors .f 3192 to 3459 273 to 6       268/273
(98 %)
0 diff
(100 %id)
AI088958 pooled .f 3203 to 3466 265 to 2       264/265
(99 %)
0 diff
(100 %id)
AI283355 ovary, tumor, 5 pooled (see description) .f 3207 to 3465 259 to 1       259/259
(100 %)
0 diff
(100 %id)
DB507553 testis .f 3216 to 3464 1 to 250     Submitted on the opposite strand 250/250
(100 %)
4 diff
(98.4 %id)
CB048816 Prostate .f 3227 to 3464 288 to 49   fully sequenced, AAA   240/240
(100 %)
4 diff
(98.4 %id)
AI796466 2 pooled tumors (clear cell type), Kidney .f 3228 to 3468 244 to 4       241/244
(98 %)
0 diff
(100 %id)
AW273931 pooled .f 3230 to 3464 235 to 1       235/235
(100 %)
0 diff
(100 %id)
AA693458   .f 3241 to 3464 266 to 43   AAA   224/224
(100 %)
0 diff
(100 %id)
AI689444 serous papillary carcinoma, high grade, 2pooled tumors, uterus .f 3273 to 3468 196 to 1       196/196
(100 %)
0 diff
(100 %id)
F10458 brain, total brain .f 3301 to 3464 164 to 1       164/164
(100 %)
1 diff
(99.4 %id)
AW087597 pooled .f 3309 to 3461 153 to 1       153/153
(100 %)
0 diff
(100 %id)
R12362 liver and spleen .f 3317 to 3469 154 to 1   fully sequenced,   154/154
(100 %)
3 diff
(98.1 %id)
CN371020 embryonic stem cells, cell lines H1, H7, andH9 .f 3358 to 3841 1 to 484   tiling clone,   484/484
(100 %)
0 diff
(100 %id)
CN371019 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .f 3557 to 4190 1 to 634   tiling clone,   634/634
(100 %)
1 diff
(99.9 %id)
AB209062 brain .g 1 to 4230 1 to 4230 exact tiling clone,   4230/4230
(100 %)
0 diff
(100 %id)
CT004969 T-Lymphocytes .g 724 to 1514 1 to 794       794/797
(99 %)
8 diff
(99.0 %id)
CN425863 embryonic stem cells, cell lines H1, H7, andH9 .g 851 to 1503 1 to 654       654/654
(100 %)
3 diff
(99.6 %id)
CN425866 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .g 939 to 1712 1 to 774       774/778
(99 %)
1 diff
(99.9 %id)
CN425867 embryonic stem cells, cell lines H1, H7, andH9 .g 1129 to 1745 1 to 617       617/617
(100 %)
3 diff
(99.6 %id)
CN425864 embryonic stem cells, cell lines H1, H7, andH9 .g 1148 to 1674 1 to 527       527/527
(100 %)
0 diff
(100 %id)
BE767282 nervous_tumor .g 1311 to 1489 195 to 19       177/196
(90 %)
1 diff
(99.5 %id)
CV569286 cornea, eye .g 1521 to 2115 1 to 595       595/595
(100 %)
0 diff
(100 %id)
TI_57178810   .g 1572 to 2110 59 to 605       547/738
(74 %)
20 diff
(97.3 %id)
TI_154151418   .g 1612 to 1932 78 to 398       321/552
(58 %)
4 diff
(99.3 %id)
CN416009 embryonic stem cells, cell lines H1, H7, andH9 .g 1635 to 2161 1 to 527       527/527
(100 %)
0 diff
(100 %id)
BM554702 duodenal adenocarcinoma, cell line, small intestine .g 1660 to 2482 1 to 830       830/1103
(75 %)
32 diff
(97.1 %id)
TI_149286023   .g 1663 to 1969 333 to 27       307/874
(35 %)
0 diff
(100 %id)
BY796624 eye .g 1703 to 2225 1 to 523       523/523
(100 %)
0 diff
(100 %id)
BF765152 colon_est .g 1967 to 2268 302 to 1     Submitted on the opposite strand 302/302
(100 %)
0 diff
(100 %id)
TI_1948231070   .g 2119 to 3057 1068 to 130       939/1348
(69 %)
20 diff
(98.6 %id)
TI_1948231568   .g 2119 to 3057 1062 to 129   AAA   934/1374
(67 %)
21 diff
(98.5 %id)
TI_1948231822   .g 2119 to 3057 1068 to 129       940/1423
(66 %)
33 diff
(97.7 %id)
CR988697 T-Lymphocytes .g 2338 to 3048 18 to 729       712/729
(97 %)
6 diff
(99.2 %id)
CN422169 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .h 1 to 500 1 to 500   tiling clone,   500/500
(100 %)
0 diff
(100 %id)
BM471630 eye, retinoblastoma .h 187 to 1104 1 to 929   tiling clone,   929/1063
(87 %)
40 diff
(96.3 %id)
DB061045 testis .i 1 to 532 2 to 535   tiling clone, capped   534/534
(100 %)
2 diff
(99.7 %id)
CR988242 T-Lymphocytes .i 512 to 1360 1 to 849   tiling clone,   849/850
(99 %)
1 diff
(99.9 %id)
AA135162 colon, tumor .i 782 to 1210 430 to 1       428/430
(99 %)
12 diff
(97.3 %id)
BM905845 leiomyosarcoma, uterus .j 1 to 409 1 to 420   tiling clone, AAA   420/964
(43 %)
19 diff
(98.1 %id)
CU454663 epidermis .j 380 to 1152 781 to 9   tiling clone, Submitted on the opposite strand 773/781
(98 %)
0 diff
(100 %id)
CU442946 epidermis .j 452 to 1152 708 to 9     Submitted on the opposite strand 700/708
(98 %)
2 diff
(99.8 %id)
BE795686 lung, small cell carcinoma .j 551 to 1157 1 to 607   tiling clone,   607/995
(61 %)
1 diff
(99.9 %id)
AI278846 carcinoid, lung .j 738 to 1142 416 to 12   AAA   405/433
(93 %)
2 diff
(99.6 %id)
AY240961   .k 1 to 2579 1 to 2579 exact tiling clone, AAA Possibly primed on the genome, locally A rich (15/18 A in genome downstream of last aligned base) 2579/2579
(100 %)
0 diff
(100 %id)
BU070891 insulinoma, Pancreas .k 1093 to 1703 1 to 611       611/611
(100 %)
5 diff
(99.2 %id)
BU070654 insulinoma, Pancreas .k 2020 to 2575 556 to 1       556/556
(100 %)
1 diff
(99.9 %id)
CR987797 T-Lymphocytes .l-u 1 to 614 1 to 615 exact tiling clone,   615/616
(99 %)
2 diff
(99.7 %id)
Z45793 brain, total brain .l-u 298 to 575 1 to 278   tiling clone,   278/278
(100 %)
1 diff
(99.7 %id)
AI683236 serous papillary carcinoma, high grade, 2pooled tumors, uterus .m 1 to 640 640 to 1   tiling clone,   640/655
(97 %)
7 diff
(99.0 %id)
DB078090 testis .m 94 to 653 2 to 561 exact tiling clone, capped   560/560
(100 %)
0 diff
(100 %id)
BM876556 insulinoma, Pancreas .n 1 to 477 1 to 477 F2R tiling clone, fully sequenced, Possibly primed on the genome, locally A rich (15/18 A in genome downstream of last aligned base) 477/477
(100 %)
5 diff
(99.0 %id)
BM876295 insulinoma, Pancreas .n 447 to 892 461 to 16   tiling clone, fully sequenced, AAA Possibly primed on the genome, locally A rich (15/18 A in genome downstream of last aligned base) 446/446
(100 %)
0 diff
(100 %id)
BG006131 placenta_normal .o 1 to 480 11 to 491 R2G F96L S100R M101H L102V ... tiling clone,   481/491
(97 %)
15 diff
(97.0 %id)
CN425869 embryonic stem cells, cell lines H1, H7, andH9 .p 1 to 599 1 to 599 V95G tiling clone,   599/599
(100 %)
3 diff
(99.5 %id)
CN425862 embryonic stem cells, cell lines H1, H7, andH9 .p 120 to 356 1 to 237   tiling clone,   237/237
(100 %)
2 diff
(99.2 %id)
AL832528 brain .q 1 to 3859 1 to 3862 exact tiling clone, available from DKFZ,   3862/3870
(99 %)
8 diff
(99.8 %id)
AA334607   .q 17 to 305 1 to 290       290/290
(100 %)
3 diff
(99.0 %id)
BF769098 epid_tumor .q 269 to 853 1 to 574   tiling clone,   574/574
(100 %)
17 diff
(97.1 %id)
DW458660 Liver .r-u 1 to 137 16 to 153 P23A T24N K25Q H26A H27P ... tiling clone,   138/153
(90 %)
6 diff
(96.1 %id)
DW458944 Liver .r-u 1 to 136 16 to 151 H27Q tiling clone,   136/151
(90 %)
6 diff
(96.1 %id)
AF141870 Liver Gene ILF3, variant not shown         Suspected internal deletion, this clone was ignored    
AK293170   Gene ILF3, variant not shown         Suspected internal deletion, this clone was ignored    
AK294084 alzheimer cortex Gene ILF3, variant not shown         Suspected internal deletion, this clone was ignored    
407 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l-u, .m, .n, .o, .p, .q, .r-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI